Inovio Pharmaceuticals, Inc. (INO) - NASDAQ
Company Description
Inovio Pharmaceuticals, Inc. is a bio-pharmaceutical company, which develops active DNA immunotherapies for cancer and infectious diseases. Its portfolio of immune therapies include SynCon immunotherapies and electroporation delivery systems. The company was founded on June 29, 1983 and is... More
Sector: Healthcare
Industry: Biotechnology
Country: United States